http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f73d45495441f164eb8dc225b3b2bd12
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Yang |
| name | Baofeng Yang |
| given-name | Baofeng |
| organization-name | Health and Family Planning Commission of Hebei, Shijiazhuang, Hebei 050000, P.R. China From the Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Heilongjiang, China (Ying Zhang, L.J., L.S., Y. Li, Y.G., C.X., Y.S., M.L., C.L., Y. Lu, Z.P., L.X., Yiyuan Zhang, Q.L., R.Y., Y. Zhuang, Yong Zhang, B.Y.); Department of Pharmacology and Therapeutics, Melbourne School of Biomedical Sciences, Dentistry, and Health Sciences, University of Melbourne, Australia (B.Y.). Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China; Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence (Fudan University), Ministry of Education, China Authors' Affiliations: 1Department of Surgery, Surgical Research Laboratories, and 2Department of Gynecological Oncology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, the Netherlands; 3Department of General Surgery, The First Affiliated Hospital of Harbin Medical University; and 4Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University, Harbin, Heilongjiang, China Department of Pharmacology, Harbin Medical University, Harbin, China. Department of Pharmacology, The State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Harbin, Heilongjiang Province, China Department of Pharmacology (State-Province Key Laboratories of Biomedicine- Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province, P. R. China; Institute of Medical Sciences of Heilongjiang Province, Harbin, P.R. China; Department of Pharmacology and Therapeutics, Melbourne School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australian Department of Pharmacology, Harbin Medical University, Harbin, China Department of Pharmacology , Harbin , People’s Republic of China; State Province Key Laboratories of Biomedicine and Pharmaceutics of China , Harbin , People’s Republic of China; Key Laboratory of Cardiovascular Research , Harbin , People’s Republic of China; Ministry of Education , Harbin , People’s Republic of China; College of Pharmacy , Harbin , People’s Republic of China; Harbin Medical University , Harbin , People’s Republic of China; Department of Pharmacology and Therapeutics , Melbourne, VIC, Australia; Melbourne School of Biomedical Sciences , Melbourne, VIC, Australia; Faculty of Medicine, Dentistry and Health Sciences , Melbourne, VIC, Australia; University of Melbourne , Melbourne, VIC, Australia Department of Pharmacology and the State‐Province Key Laboratory of Biomedicine and Pharmaceutics Harbin Medical University Harbin Heilongjiang Province P.R. China Department of Pharmacology (State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education) Harbin Medical University Harbin Heilongjiang China; Institute of Cardiovascular Research Harbin Medical University Harbin Heilongjiang China Department of Pharmacology, State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University; Cardiovascular Research Institute, Harbin Medical University 1 Department of Bioinformatics, Bio-pharmaceutical Key Laboratory of Heilongjiang Province-Incubator of State Key Laboratory, Harbin Medical University, Harbin 150086 and 2Bioinformatics Centre and School of Life Science, University of Electronic Science and Technology of China, Chengdu, 610054, China From the Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada (M.H., X.L., S.N.); Department of Cardiology, Hamamatsu Medical Center, Hamamatsu, Japan (M.H.); Cardiovascular Research Institute and Department of Pharmacology, Harbin Medical University, Harbin, People’s Republic of China (X.L.; B.Y.); Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan (T.M.); and Institute of Pharmacology, Faculty... Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China; Institute of Cardiovascular Research, Harbin Medical University, Harbin, Heilongjiang 150086, People's Republic of China Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Heilongjiang, China (Y.Y., Y.Z., J.Y., M.Z., T.T., Y.J., X.L., G.X., X.L., X.Z., S.L., X.H., Z.L., Y.G., L.Z., H.B., Z. Zhou, J.S., G.Y., L.X., H.S., Y.L., B.Y., Z.P.). Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China. From the Division of Pharmacology, College of Pharmacy (J.J., V.G., T.S.E., K.H.), and Davis Heart and Lung Research Institute (T.S.E.), Ohio State University, Columbus; and the Department of Pharmacology (B.Y.), Harbin Medical University, Harbin, Heilongjiang, China. Department of Pharmacology (Key Laboratory of Cardiovascular Medicine Research, Ministry of Education; State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China) Harbin Medical University Harbin Heilongjiang China From Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China) (Y.L., Y.Z., N.W., Z.P., Y.Z., H.S., X.L., Y.B., L.S., C.X., Z.W., B.Y.), and Department of Biochemistry (X.G.), Department of Microbiology (F.Z., W.S.), Harbin Medical University, Harbin, Heilongjiang 150081, P. R. China, and Montreal Heart Institute and Department of Medicine, Université de Montréal (Z.W., X.L.), Montreal, Canada. Departments of Pathophysiology and Pharmacology and The Institute for Keshan Disease, Harbin Medical University, Harbin 150086, China, and Department of Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Kyushu University, Fukuoka 812-8582, Japan From the Department of Pharmacology (The Key Laboratory of Cardiovascular Research, Ministry of Education) at College of Pharmacy (B.C., Yang Zhang, Y. Zhao, J.W., T.L., Yiyuan Zhang, Y.J., X.J., G.X., P.L., Yilin Sun, Q.H., X.Z., W.S., Y.Y., Yangyang Sun, L.S., X.L., Y.L., B.Y., Z.P.), Harbin Medical University, China. Department of Pharmacology, Harbin Medical University; State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Harbin Medical University Department of Pharmacology and Bio-pharmaceutical Key Laboratory of Heilongjiang Province and State, Harbin Medical University 2 2 Harbin 150086, China From the Research Center, Montreal Heart Institute, Montreal, Canada (J.W., H.W., H.H., Y.Z., Z.W.); the Department of Medicine, University of Montreal, Montreal, Canada (J.W., Y.Z., Z.W.); the Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada (S.N.); and the Department of Pharmacology, Harbin Medical University, Harbin, Heilongjiang, China (B.Y.). Department of Pharmacology (State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin P. R. China; Translational Medicine Research and Cooperation Center of Northern China Heilongjiang Academy of Medical Sciences Harbin P. R. China Department of Pharmacology Harbin Medical University (the State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education) College of Pharmacy Harbin Medical University Harbin, Heilongjiang China Department of Hematology, First Affiliated Hospital, Harbin Medical University, Harbin, China Department of Pharmacology (State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China; National Key Laboratory of Frigid Zone Cardiovascular Diseases (NKLFZCD) Harbin China; Research Unit of Noninfectious Chronic Diseases in Frigid Zone, 2019RU070 Chinese Academy of Medical Sciences Harbin China Department of Pharmacology State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education, Harbin Medical University, Harbin, Heilongjiang 150081, P. R. China Department of Pharmacology (The State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China) Harbin Medical University Harbin China; Department of Pharmacology and Therapeutics Melbourne School of Biomedical Sciences Faculty of Medicine, Dentistry and Health Sciences University of Melbourne Melbourne Vic. Australia Department of Medicine, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada H3C 3J7; and Department of Pharmacology, The Key Laboratory of Cardiovascular Research, Ministry of Education, College of Pharmacy, Harbin Medical University, Harbin 150067, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin 150081, China Department of Pharmacology, New York Medical College, Valhalla, NY 10595; Department of Pharmacology, Harbin Medical University, Harbin 150086, China; and Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT 06520 From the Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), Harbin Medical University, Harbin, China. Department of Pharmacology Harbin Medical University Harbin China Institute of Science and Technology for Brain‐Inspired Intelligence Fudan University Shanghai China Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China; Research Unit of Noninfectious Chronic Diseases in Frigid Zone, Chinese Academy of Medical Sciences, Harbin, China Harbin Medical University, Harbin 150086, China Department of Pharmacology, State Province Key Laboratories of Biomedicine-Pharmaceutics of China and Key Laboratories of Cardiovascular Research, Ministry of Education of China, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China; Cardiovascular Research Institute, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China Department of Pharmacy the Daqing Oilfield General Hospital Daqing Heilongjiang China Departments of Medicine and Department of Pharmacology (State‐Province Key Laboratories of Biomedicine‐Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education) College of Pharmacy Harbin Medical University Harbin China Institute of Science and Technology for Brain-inspired Intelligence, Fudan University From the Department of Medicine and Research Center, Montreal Heart Institute, University of Montreal (H.W., H.S., L.Z., M.P., S.N., Z.W.), and Department of Pharmacology and Therapeutics, McGill University (S.N.), Montreal, Quebec, Canada, and the Department of Pharmacology, Harbin Medical University, Harbin, China (B.Y., Z.W.). |
Incoming Links
Total number of triples: 360.